Pharmaceutical Counterfeiting in the EU: Where Are We Now?Informa HealthcareMay 1, 2007 107 Pages - SKU: IFHC1693947 |
Enter a term to search inside this document.
|
Use the same search language as you do when searching for reports Search terms are implicitly ORed together. This means that a search for Bottled Water is equivalent to a search for Bottled OR Water. In this scenario, only sections that contain either the word 'Bottled' or the word 'Water' will have ""Keywords in Context"" results. To find sections that contain all of the search terms, separate the search terms with 'AND' ex Bottled AND Water |
Related Markets
Regulation & Policy Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
- Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
- Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
